New study: Natural compound in fruits and vegetables may reduce ALS and dementia symptoms

Reading time: 3 minutes
By Jamie Olivos
- in

New YorkResearchers at the University of Missouri, led by Professor Smita Saxena, have discovered a promising natural compound that might help with ALS and dementia. This compound, called kaempferol, is found in fruits and vegetables like kale and berries. It shows potential in protecting nerve cells and maintaining motor function. In lab-grown cells from ALS patients, kaempferol improved energy production and reduced stress in the cells. This means it could slow down nerve cell damage.

The challenge with kaempferol is that our bodies don't absorb it well from food, and it’s hard for it to reach the brain. To address this, Saxena's team is exploring ways to enhance its absorption using lipid-based nanoparticles. These nanoparticles could make it easier for kaempferol to be absorbed by neurons in the brain, increasing its effectiveness. The team aims to test these nanoparticles soon, offering hope for new treatments for neurodegenerative diseases like ALS.

Current Challenges

One of the main challenges in using kaempferol to treat ALS and dementia is absorption. Our bodies struggle to absorb this compound from fruits and vegetables. If you eat a lot of kale or berries, only a tiny amount of kaempferol ends up reaching your tissues. For any potential benefits in treating conditions like ALS, you would need to consume a massive amount of these foods daily. This is not practical.

Another issue is getting kaempferol to the brain. The blood-brain barrier acts like a security wall to protect the brain from harmful substances. However, it also blocks many large molecules, including kaempferol. This makes it difficult for the compound to reach the nerve cells where it's needed most.

To tackle these issues, researchers are investigating new methods. One idea is to use lipid-based nanoparticles to deliver kaempferol. These tiny particles can carry the compound and help it absorb more efficiently into the body. They may also have a better chance of crossing the blood-brain barrier.

This approach is still in the early stages. If successful, it could significantly improve how kaempferol is delivered and how effective it is in treating neurodegenerative diseases. The research is promising but translating lab findings to real-world treatments will take time. Scientists are working on these technical challenges to develop a viable way to make kaempferol a part of treatment plans for ALS and dementia.

Future Prospects

The study sheds light on potential future treatments for ALS and dementia through the use of kaempferol, a compound found in everyday fruits and vegetables. Despite the initial challenges in absorption, the potential benefits are significant. Researchers are now focusing on improving how the body absorbs kaempferol, which could be a game-changer for neurodegenerative diseases.

One promising approach involves using nanoparticles made from lipids to deliver kaempferol. This technique could enhance the rate of absorption and ensure the compound reaches the brain, bypassing the blood-brain barrier more effectively. By improving delivery methods, kaempferol’s potential to maintain nerve cell health could be realized, providing new therapeutic possibilities for patients.

Further research might also explore the compound’s impact on other diseases, like Alzheimer's and Parkinson's. Given that these illnesses share similar characteristics with ALS, kaempferol could have a broader application in the medical field. This underscores the importance of innovative delivery systems, not just for kaempferol but also for future natural compounds that could benefit from improved bioavailability.

While practical applications in humans may take time, this research sets a foundation for future studies. The primary goal is to develop a treatment that can seamlessly integrate into patients' lives and provide tangible benefits. As scientific breakthroughs continue, we may inch closer to solutions that could significantly impact individuals with neurodegenerative conditions. The research inspires hope that natural compounds could one day play a major role in managing and potentially alleviating the symptoms of these challenging diseases.

The study is published here:

https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-025-01927-y

and its official citation - including authors and journal - is

Federica Pilotto, Paulien Hermine Smeele, Olivier Scheidegger, Rim Diab, Martina Schobesberger, Julieth Andrea Sierra-Delgado, Smita Saxena. Kaempferol enhances ER-mitochondria coupling and protects motor neurons from mitochondrial dysfunction and ER stress in C9ORF72-ALS. Acta Neuropathologica Communications, 2025; 13 (1) DOI: 10.1186/s40478-025-01927-y

as well as the corresponding primary news reference.

Environment: Latest Findings
Read more:

Share this article

Comments (0)

Post a Comment
The Science Herald

The Science Herald is a weekly magazine covering the latest in science, from tech breakthroughs to the economics of climate change. It aims to break down complex topics into articles that are understandable to a general audience. Hence with engaging storytelling we aim to bring scientific concepts within reach without oversimplifying important details. Whether you're a curious learner or a seasoned expert in the field covered, we hope to serve as window into the fascinating world of scientific progress.

Follow Us


© 2024 The Science Herald™. All Rights Reserved.